EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sentinel lymph nodes biopsy for malignant tumors using Technefit radioactive colloid Technetium 99mTc

Irina Onofriychuk iD, Aziz Zikiryahodzhaev iD, Anatoliy Ermakov, Nataliya Ablitsova iD, Eric Saribekyan iD, Elena Rasskazova iD, Gadgimurad Zapirov iD, Stanislav Mikhailov iD, Andrey Kaprin iD, Anna Sukhotko iD, Serghei Covantsev iD

Folia Medica · 2024

DOI: 10.3897/folmed.66.e134377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Medica, 2024. Verfasst von Irina Onofriychuk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Moscow Research Institute of Oncology n.a. P.A. Herzen - Branch of the National Medical Research Centre of Radiology, Moscow, Russia. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Sentinel Lymph Node Biopsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Technetium-99m ( 99m Tc) is a short-lived nanocolloid nuclide widely used by oncologists to diagnose and identify cancer dissemination.

Aim

The aim of the current study was to develop the technique of radiopharmaceutical preparation (RPP) of Technefit 99m Tc aimed at examining sentinel lymph nodes (SLN) before surgery. Materials and methods : We performed a series of trials (33 patients). Based on the information obtained from the portable gamma detector NEO2000 during surgery, a biopsy of the sentinel lymph nodes was carried out when RPP Technefit 99m Tc accumulated in a specific lymph node.

Results

We determined maximum activities, volume, and peculiarities of administration of radioactive colloid Technefit 99m Tc in order to examine and perform the biopsy of SLN in the patients with malignant tumors. The most informative results in terms of scintigraphy images of sentinel lymph nodes were revealed in the first trial of the research, with all 5 cases (100%) showing positive results. The first trial included Technefit intradermal-hypodermal injection into one point above the tumor node, RPP activity of 75 to 200 mBq at a room temperature of 21°C, without preliminary anesthesia with Novocain solution.

Conclusion

We determined the most efficient dosages of activities, volume, and characteristics of radioactive colloid administration aimed at the examination and biopsy of sentinel lymph nodes using the radiopharmaceutical preparation Technefit 99m Tc in patients with malignant tumors of different localizations, namely breast cancer and skin melanoma. In some cases, we did not find any signs of considerable lowering of the Technefit 99m Tc activity, which shows that there is a very slow filtration of Technefit 99m Tc through the pores of lymph capillaries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiopharmaceuticalsSentinel Lymph Node BiopsyHumansLymphatic MetastasisNeoplasmsRadionuclide ImagingTechnetiumTechnetium Tc 99m Aggregated Albumin

Stichwörter der Autor:innen

biopsy of sentinel lymph node breast cancer colloid radiopharmaceutical prepara…

Substanzen

RadiopharmaceuticalsTechnetiumTechnetium Tc 99m Aggregated Albumin

Autor:innen und Institutionen

  • Moscow Research Institute of Oncology n.a. P.A. Herzen - Branch of the National Medical Research Centre of Radiology, Moscow, Russia.
  • Peoples' Friendship University of Russia n.a. Patrice Lumumba, Moscow, Russia.
  • National Medical Research Centre of Radiology of Ministry of Health of Russian Federation, Moscow, Russia.
  • Botkin Hospital, Moscow, Russia.

ORCID-Profile: Irina Onofriychuk, Aziz Zikiryahodzhaev, Nataliya Ablitsova, Eric Saribekyan, Elena Rasskazova, Gadgimurad Zapirov, Stanislav Mikhailov, Andrey Kaprin, Anna Sukhotko, Serghei Covantsev

Zitieren

APA

Onofriychuk, I., Zikiryahodzhaev, A., Ermakov, A., Ablitsova, N., Saribekyan, E., Rasskazova, E., Zapirov, G., Mikhailov, S., Kaprin, A., Sukhotko, A., & Covantsev, S. (2024). Sentinel lymph nodes biopsy for malignant tumors using Technefit radioactive colloid Technetium 99mTc. Folia Medica. https://doi.org/10.3897/folmed.66.e134377

Vancouver

Onofriychuk I, Zikiryahodzhaev A, Ermakov A, Ablitsova N, Saribekyan E, Rasskazova E, et al. Sentinel lymph nodes biopsy for malignant tumors using Technefit radioactive colloid Technetium 99mTc. Folia Medica. 2024. doi:10.3897/folmed.66.e134377

BibTeX
@article{Onofriychuk2024,
  author = {Onofriychuk, Irina and Zikiryahodzhaev, Aziz and Ermakov, Anatoliy and Ablitsova, Nataliya and Saribekyan, Eric and Rasskazova, Elena and Zapirov, Gadgimurad and Mikhailov, Stanislav and Kaprin, Andrey and Sukhotko, Anna and Covantsev, Serghei},
  title = {Sentinel lymph nodes biopsy for malignant tumors using Technefit radioactive colloid Technetium 99mTc},
  journal = {Folia Medica},
  year = {2024},
  doi = {10.3897/folmed.66.e134377}
}
Kostenlos starten →